Kaposi's Sarcoma: topical treatments

Authors

  • Federico Pastore César Milstein Institute, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v29i1.2425

Keywords:

Kaposi's sarcoma, treatments

Abstract

Kaposi's sarcoma (SK) is an angioproliferative tumor associated with the herpes virus 8. Depending on the clinical form it develops and the patient's immune status, it can manifest as a single skin lesion or be a disseminated disease.

The treatment will depend on the clinical form, the extent of the lesions and the pre-existing medical conditions. This will range from clinical observation, topical and intralesional treatments, surgery, cryotherapy, initial radiotherapy or optimization of antiretroviral therapy to systemic chemotherapy.

Topical treatment is an option for some patients with cutaneous KS, as it achieves higher local concentrations with fewer local and systemic adverse effects.

The three most widely used drugs are timolol, imiquimod, and alitretinoin, with good relative efficacy and a favorable safety profile.

Author Biography

Federico Pastore, César Milstein Institute, Autonomous City of Buenos Aires, Argentina

Dermatologist and Legist. Dermatology Plant Physician, Hospital Dr. Enrique Tornú. Head of the Dermatology Service

References

I. Htet KZ, Waul MA, Leslie KS. Topical treatments for Kaposi sarcoma: A systematic review. Skin Health Dis. 2022;2:e107.

Published

2023-04-01

Issue

Section

Dermatological Pearls